摘要
摘要David Dodwell团队分析高质量循证医学证据背景下乳腺癌治疗差异的原因。
机构地区
Nuffield Department of Population Health, University of Oxford, Oxford, UK,Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK,Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford; Department of Surgery, Oxford University Hospitals NHS Fo
出版日期
2021年05月08日（中国期刊网平台首次上网日期，不代表论文的发表时间）
